<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Painchek Ltd — News on 6ix</title>
    <link>https://6ix.com/company/painchek-ltd</link>
    <description>Latest news and press releases for Painchek Ltd on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 14 Apr 2026 03:39:04 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/painchek-ltd" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836691c78dffbe2df15efc1.webp</url>
      <title>Painchek Ltd</title>
      <link>https://6ix.com/company/painchek-ltd</link>
    </image>
    <item>
      <title>Landmark Sabra North America deployment targeting 20k beds</title>
      <link>https://6ix.com/company/painchek-ltd/news/landmark-sabra-north-america-deployment-targeting-20k-beds</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/landmark-sabra-north-america-deployment-targeting-20k-beds</guid>
      <pubDate>Tue, 14 Apr 2026 03:39:04 GMT</pubDate>
      <description>Landmark Sabra North America deployment targeting 20k beds</description>
    </item>
    <item>
      <title>PainChek reports material sales momentum in UK</title>
      <link>https://6ix.com/company/painchek-ltd/news/painchek-reports-material-sales-momentum-in-uk</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/painchek-reports-material-sales-momentum-in-uk</guid>
      <pubDate>Thu, 26 Mar 2026 02:15:05 GMT</pubDate>
      <description>PainChek reports material sales momentum in UK</description>
    </item>
    <item>
      <title>Half Yearly Report and Accounts</title>
      <link>https://6ix.com/company/painchek-ltd/news/half-yearly-report-and-accounts-199</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/half-yearly-report-and-accounts-199</guid>
      <pubDate>Fri, 27 Feb 2026 08:40:09 GMT</pubDate>
      <description>Half Yearly Report and Accounts</description>
    </item>
    <item>
      <title>Quarterly Activities/Appendix 4C Cash Flow Report</title>
      <link>https://6ix.com/company/painchek-ltd/news/quarterly-activitiesappendix-4c-cash-flow-report-39</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/quarterly-activitiesappendix-4c-cash-flow-report-39</guid>
      <pubDate>Fri, 30 Jan 2026 03:28:21 GMT</pubDate>
      <description>Quarterly Activities/Appendix 4C Cash Flow Report</description>
    </item>
    <item>
      <title>PainChek Business Update</title>
      <link>https://6ix.com/company/painchek-ltd/news/painchek-business-update</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/painchek-business-update</guid>
      <pubDate>Fri, 30 Jan 2026 03:28:21 GMT</pubDate>
      <description>PainChek Business Update</description>
    </item>
    <item>
      <title>PainChek gains access to RTM reimbursement in USA</title>
      <link>https://6ix.com/company/painchek-ltd/news/painchek-gains-access-to-rtm-reimbursement-in-usa</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/painchek-gains-access-to-rtm-reimbursement-in-usa</guid>
      <pubDate>Thu, 29 Jan 2026 03:12:20 GMT</pubDate>
      <description>PainChek gains access to RTM reimbursement in USA</description>
    </item>
    <item>
      <title>AGM Presentation</title>
      <link>https://6ix.com/company/painchek-ltd/news/agm-presentation-56</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/agm-presentation-56</guid>
      <pubDate>Wed, 26 Nov 2025 04:42:03 GMT</pubDate>
      <description>AGM Presentation</description>
    </item>
    <item>
      <title>Investor Presentation</title>
      <link>https://6ix.com/company/painchek-ltd/news/investor-presentation-262</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/investor-presentation-262</guid>
      <pubDate>Fri, 31 Oct 2025 02:28:19 GMT</pubDate>
      <description>Investor Presentation</description>
    </item>
    <item>
      <title>Notice of Annual General Meeting/Proxy Form</title>
      <link>https://6ix.com/company/painchek-ltd/news/notice-of-annual-general-meetingproxy-form-7</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/notice-of-annual-general-meetingproxy-form-7</guid>
      <pubDate>Fri, 24 Oct 2025 05:01:04 GMT</pubDate>
      <description>Notice of Annual General Meeting/Proxy Form</description>
    </item>
    <item>
      <title>Key hire to drive Infant App in $15Bn addressable market</title>
      <link>https://6ix.com/company/painchek-ltd/news/key-hire-to-drive-infant-app-in-dollar15bn-addressable-market</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/key-hire-to-drive-infant-app-in-dollar15bn-addressable-market</guid>
      <pubDate>Fri, 17 Oct 2025 01:53:19 GMT</pubDate>
      <description>Key hire to drive Infant App in $15Bn addressable market</description>
    </item>
    <item>
      <title>Response to ASX Aware Letter</title>
      <link>https://6ix.com/company/painchek-ltd/news/response-to-asx-aware-letter-50</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/response-to-asx-aware-letter-50</guid>
      <pubDate>Thu, 16 Oct 2025 08:14:11 GMT</pubDate>
      <description>Response to ASX Aware Letter</description>
    </item>
    <item>
      <title>PainChek Secures First US Customer Following FDA Clearance</title>
      <link>https://6ix.com/company/painchek-ltd/news/painchek-secures-first-us-customer-following-fda-clearance</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/painchek-secures-first-us-customer-following-fda-clearance</guid>
      <pubDate>Mon, 13 Oct 2025 01:38:45 GMT</pubDate>
      <description>PainChek Secures First US Customer Following FDA Clearance</description>
    </item>
    <item>
      <title>PainChek FDA Cleared to Commence Sales in US$100M US Market</title>
      <link>https://6ix.com/company/painchek-ltd/news/painchek-fda-cleared-to-commence-sales-in-usdollar100m-us-market</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/painchek-fda-cleared-to-commence-sales-in-usdollar100m-us-market</guid>
      <pubDate>Wed, 08 Oct 2025 04:20:09 GMT</pubDate>
      <description>PainChek FDA Cleared to Commence Sales in US$100M US Market</description>
    </item>
    <item>
      <title>Trading Halt</title>
      <link>https://6ix.com/company/painchek-ltd/news/trading-halt-425</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/trading-halt-425</guid>
      <pubDate>Tue, 07 Oct 2025 02:44:14 GMT</pubDate>
      <description>Trading Halt</description>
    </item>
    <item>
      <title>Compelling Clinical and Economic Results in Scottish Pilot</title>
      <link>https://6ix.com/company/painchek-ltd/news/compelling-clinical-and-economic-results-in-scottish-pilot</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/compelling-clinical-and-economic-results-in-scottish-pilot</guid>
      <pubDate>Wed, 17 Sep 2025 03:25:21 GMT</pubDate>
      <description>Compelling Clinical and Economic Results in Scottish Pilot</description>
    </item>
    <item>
      <title>Preliminary Final Report</title>
      <link>https://6ix.com/company/painchek-ltd/news/preliminary-final-report-127</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/preliminary-final-report-127</guid>
      <pubDate>Fri, 29 Aug 2025 02:47:42 GMT</pubDate>
      <description>Preliminary Final Report</description>
    </item>
    <item>
      <title>Strongly Supported A$7.5m Placement to Drive Int. Growth</title>
      <link>https://6ix.com/company/painchek-ltd/news/strongly-supported-adollar75m-placement-to-drive-int-growth</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/strongly-supported-adollar75m-placement-to-drive-int-growth</guid>
      <pubDate>Mon, 28 Jul 2025 04:19:15 GMT</pubDate>
      <description>Strongly Supported A$7.5m Placement to Drive Int. Growth</description>
    </item>
    <item>
      <title>Final US FDA De Novo Clearance Submission Completed</title>
      <link>https://6ix.com/company/painchek-ltd/news/final-us-fda-de-novo-clearance-submission-completed</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/final-us-fda-de-novo-clearance-submission-completed</guid>
      <pubDate>Mon, 21 Jul 2025 03:22:24 GMT</pubDate>
      <description>Final US FDA De Novo Clearance Submission Completed</description>
    </item>
    <item>
      <title>PainChek Reports Strong Quarterly Sales Growth</title>
      <link>https://6ix.com/company/painchek-ltd/news/painchek-reports-strong-quarterly-sales-growth</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/painchek-reports-strong-quarterly-sales-growth</guid>
      <pubDate>Thu, 03 Jul 2025 03:22:18 GMT</pubDate>
      <description>PainChek Reports Strong Quarterly Sales Growth</description>
    </item>
    <item>
      <title>PainChek has productive final FDA De Novo clearance meeting</title>
      <link>https://6ix.com/company/painchek-ltd/news/painchek-has-productive-final-fda-de-novo-clearance-meeting</link>
      <guid isPermaLink="true">https://6ix.com/company/painchek-ltd/news/painchek-has-productive-final-fda-de-novo-clearance-meeting</guid>
      <pubDate>Thu, 05 Jun 2025 02:53:16 GMT</pubDate>
      <description>PainChek has productive final FDA De Novo clearance meeting</description>
    </item>
  </channel>
</rss>